LY6G6D Protein, Human, Recombinant (His)

产品编号 TMPK-00753

LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy. LY6G6D Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 10.20 kDa and the accession number is O95868.

LY6G6D Protein, Human, Recombinant (His)

产品编号 TMPK-00753

规格	价格	库存
100 μg	¥ 3,100	5日内发货
500 μg	¥ 12,400	5日内发货
1 mg	¥ 20,700	5日内发货

大包装 & 定制

加入购物车

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

问PEG300 可以用 PEG400 替代吗？

答PEG300 具有适度的粘稠度，有利于药物的溶解和给药过程，同时也能够提供良好的耐受性，不会对动物造成不良影响。PEG400 可以替代 PEG300。 PEG600 不是很建议，因为熔点接近常温。

问抑制剂能否用于细胞实验？

答可以的，我们的抑制剂都可以用于细胞/体外实验。但有些化合物还没有用于细胞实验的文献，这种情况下，建议您先做预实验，确保研究的可行性。

问准备进行动物实验，收到大包装粉末后，如何分装溶解？

答根据配制出来的溶液是不是澄清的确定一次性能配多少：如果配制出来是澄清溶液，可以一次性多配制一些，储存于4度冰箱，大概一周配一次，放久了可能会失效；如果配制出来是混悬液，建议每次使用的时候都现配现用。

问动物实验常用溶解方法？

答首先，您需要确认给药剂量、给药方式。对于具体的产品，优先找引用我们产品的文献里的使用方法，再找其他文献里的配方。如果没有相关的文献，且该化合物的 DMSO 溶解度比较好，我们推荐通用配方: 10% DMSO+40% PEG300+5% Tween-80+45% Saline/PBS/ddH2O。溶剂依次加入，尽量溶解后再加入下一个溶剂。正常鼠建议 DMSO 浓度在 10% 以下，裸鼠体弱鼠等配方的 DMSO 浓度建议在 2% 以下，根据溶液是否澄清，助溶剂 PEG300、Tween-80 的比例可以适当调整。如果有其他助溶剂也可以使用。以上配方仅供参考，体内配方并不是绝对的，需要根据不同情况进行调整。建议先取少量化合物测试配方，再进行大量配制。配完也可以再使用超声、加热等方式助溶，看看能不能澄清一点。腹腔注射对粉末的溶解度要求比较高，建议购买盐形式化合物。如果给药剂量比较大，也有报道使用混悬液进行腹腔给药的。对于灌胃给药，且剂量比较大的情况下，建议用 0.5% CMC-Na 配置成均匀混悬液进行给药。

问超声久了会不会对化合物的结构有影响？

答建议以较低频率对化合物进行超声，不会对化合物的结构造成影响。

产品信息

生物活性	Immobilized Human LY6G6D, His Tag at 0.2μg/ml (100μl/well) on the plate. Dose response curve for Anti-LY6G6D Antibody, hFc Tag with the EC50 of 3.9ng/ml determined by ELISA.
产品描述	LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy. LY6G6D Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 10.20 kDa and the accession number is O95868.
种属	Human
表达系统	HEK293 Cells
标签	C-His
蛋白编号	O95868
别名	Protein Ly6-D,NG25,MEGT1,Ly6-D,G6D,C6orf23
蛋白构建	Asn20-Ser104
蛋白纯度	> 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
分子量	10.20 kDa (predicted). Due to glycosylation, the protein migrates to 13-15 kDa based on Tris-Bis PAGE result.
内毒素	< 1 EU/μg by the LAL method.
缓冲液	Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS (pH 7.4). Typically, 8% trehalose is incorporated as a protective agent before lyophilization.
复溶方法	Reconstitute the lyophilized protein in distilled water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing.
存储	It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式	In general, Lyophilized powders are shipping with blue ice.
研究背景	LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy.

LY6G6D Protein, Human, Recombinant (His)

LY6G6D Protein, Human, Recombinant (His)

产品信息

参考文献

SCI 文献

计算器

技术支持

关键词